| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.66 | 0.01 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.4 | 0.01 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |